Michael Secora Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Michael Secora is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.49 Million shares of RXRX, which is worth approximately $8.55 Million. The most recent transaction as insider was on Jun 13, 2023, when has been sold 37,500 shares (Class A Common Stock) at a price of $2.22 per share, resulting in proceeds of $83,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M

9.92% 3M change

59.79% 12M change

Total Value Held $8.55 Million

Michael Secora Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.32%	830,413 Class A Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$26,656 $5.6 p/Share	4,760 Reduced 0.6%	790,159 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$10,617 $8.44 p/Share	1,258 Reduced 0.16%	794,310 Class A Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$22,819 $8.55 p/Share	2,669 Reduced 0.33%	795,568 Class A Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	210,163 Added 20.84%	798,237 Class A Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$12,630 $11.86 p/Share	1,065 Reduced 0.18%	586,572 Class A Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$13,802 $12.96 p/Share	1,065 Reduced 0.18%	587,637 Class A Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$6,061 $5.67 p/Share	1,069 Reduced 0.18%	588,702 Class A Common Stock
Feb 04 2022	SELL Payment of exercise price or tax liability	$7,729 $11.4 p/Share	678 Reduced 0.11%	589,771 Class A Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	-	60,299 Added 9.27%	590,449 Class A Common Stock
Apr 20 2021	SELL Other acquisition or disposition	-	528,762 Reduced 100.0%	0 Common Stock
Apr 20 2021	BUY Conversion of derivative security	-	149,077 Added 21.99%	528,762 Common Stock
Apr 20 2021	BUY Other acquisition or disposition	-	528,762 Added 50.0%	528,762 Class A Common Stock

Michael Secora

Chief Financial Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account